Local Generics Win Big In China's Latest National Tender

Eisai's Lenvima Loses Out

China generics tender program
Only four multinationals secured listings for off-patent drugs in China's latest tender program • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from China

More from Focus On Asia